[1]
Dr. Khoala Riaz et al. 2025. INCIDENCE AND PREDICTIVE ACCURACY OF POST EMBOLIZATION SYNDROME FOR SURVIVAL IN HEPATOCELLULAR CARCINOMA PATIENTS AFTER TRANSARTERIAL CHEMOEMBOLIZATION. Journal of Population Therapeutics and Clinical Pharmacology. 32, 2 (Mar. 2025), 1456–1461. DOI:https://doi.org/10.53555/bbrncw19.